OJMI  Vol.3 No.4 , December 2013
Evaluation of Renal Disorders in Type 2 Diabetic Patients Using Ultrsonography
ABSTRACT

Type 2 diabetes mellitus (type 2 DM) is one of the common epidemics worldwide. The prevalence of type 2 DM is high among Saudi population. Renal affection by DM is in the form of nephropathy that may end in the end stage of renal disease (ESRD) and renal failure warrants chronic dialysis or renal transplantation. Renal Ultrasonography (US) is a simple, accurate, affordable and non-invasive test that can help in management of type 2 DM patients who have renal affection. Four hundred patients, aged from 13 - 93 years with type 2 DM were recruited from the outpatient internal and family medicine clinics at KAUH. Renal US was requested for 202 patients, and was done at the diagnostic radiology department using digital iU22 Philips machine with 3.5 - 5 MHz convex array transducer. The renal size, parenchymal echogenicity and associated renal pathologies e.g. stones, cysts or masses were evaluated. Statistical analysis was performed using SPSS program version 16. Most cases showed normal renal size and echogenicity. Grade one nephropathy was more than grade two or three. Nephropathy was non-significantly correlated to the patients’ gender, but to their age. Increased patients’ age was associated with increased renal echogenicity. Non-diabetes-related renal abnormalities were detected in 39% of patients. The most common of non-diabetes-related renal abnormalities was simple renal cyst followed by renal stones (25% and 23%) respectively. Renal US for patients with type 2 DM has a great role in diagnosing and grading diabetic nephropathy, selecting cases with non-diabetic nephropathy for renal biopsy, and detecting associated renal abnormalities. Due to the high prevalence of DM in Saudi Arabia, we recommend future expanding study of the underlying possible genetic relation between DM and renal cysts and also the relation between renal stones and type 2 DM.


Cite this paper
S. D. Jastaniah, N. M. Alsayed, I. A. Awad, H. R. Fida and H. H. Elniel, "Evaluation of Renal Disorders in Type 2 Diabetic Patients Using Ultrsonography," Open Journal of Medical Imaging, Vol. 3 No. 4, 2013, pp. 165-170. doi: 10.4236/ojmi.2013.34024.
References
[1]   P. M. Hall, “Prevention of Progression in Diabetic Nephropathy,” Diabetes Spectrum, Vol. 19, No. 1, 2006, pp. 18-24. http://dx.doi.org/10.2337/diaspect.19.1.18

[2]   A. A. Al-Khader, “Impact of Diabetes in Renal Diseases in Saudi Arabia,” Nephrology Dialysis Transplantation, Vol. 16, No. 11, 2001, pp. 2132-2135.
http://dx.doi.org/10.1093/ndt/16.11.2132

[3]   A. Al-Zaid, S. Sobki and V. De Silva, “Prevalence of Microalbuminuria in Saudi Arabians with Non-Insulin-Dependent Diabetes Mellitus—A Clinic Based Study,” Diabetes Research and Clinical Practice, Vol. 26, No. 2, 1994, pp. 115-120.
http://dx.doi.org/10.1016/0168-8227(94)90148-1

[4]   “National Kidney Foundation: Diabetes and Kidney Disease,” 2008.
http://www.kidney.org/atoz/atozItem.cfm?id=37

[5]   E. Zukowska-Szczechowska and M. Tomaszewski, “Renal Affection in Patients with Diabetes Mellitus Is Not Always Caused by Diabetic Nephropathy,” Roczniki Akademii Medycznej w Bialymstoku, Vol. 49, 2004, pp. 185-189.

[6]   C. Couchoud and E. Villar, “End-Stage Renal Disease Epidemic in Diabetics: Is There Light at the End of the Tunnel?” Nephrology Dialysis Transplantation, Vol. 28, No. 5, 2013, pp. 1073-1076.
http://dx.doi.org/10.1093/ndt/gfs559

[7]   V. Tesar, “Examination of the Kidneys in a Diabetic Patient,” Vnitrní Lékarství, Vol. 54, No. 5, 2008, pp. 494- 498.

[8]   E. Esmatjes, C. Castell, T. Gonzalez, R. Tresserras and G. Lloveras, “Epidemiology of Renal Involvement in Type II Diabetics (NIDDM) in Catalonia, the Catalan Diabetic Nephropathy Study Group,” Diabetes Research and Clinical Practice, Vol. 32, No. 3, 1996, pp. 157-163.
http://dx.doi.org/10.1016/0168-8227(96)01256-9

[9]   Y. B. Chong, T. C. Keng, L. P. Tan, K. P. Ng, W. Y. Kong, C. M. Wong, P. L. Cheah, L. M. Looi and S. Y. Tan, “Clinical Predictors of Non-Diabetic Renal Disease and Role of Renal Biopsy in Diabetic Patients with Renal Involvement: A Single Centre Review,” Renal Fail, Vol. 34, No. 3, 2012, pp. 323-328.
http://dx.doi.org/10.3109/0886022X.2011.647302

[10]   K. R. Tuttle, J. H. Stein and R. A. deFronzo, “The Natural History of Diabetic Nephropathy,” Seminars in Nephrology, Vol. 10, 1990, pp. 184-193.

[11]   B. Brooks, R. Chong, I. Ho, F. Capstick, L. Molyneaux, T. T. Oo, et al., “Diabetic Retinopathy and Nephropathy in Fiji: Comparison with Data from an Australian Diabetes Center,” Australian and New Zealand Journal of Ophthalmology, Vol. 27, No. 1, 1999, pp. 9-13.
http://dx.doi.org/10.1046/j.1440-1606.1999.00146.x

[12]   C. Bingham and A. T. Hattersley, “Renal Cysts and Diabetes 3.5-Syndrome Resulting from Mutations in Hepatocyte Nuclear Factor-1beta,” Nephrology Dialysis Transplantation, Vol. 19, No. 11, 2004, pp. 2703-2708.
http://dx.doi.org/10.1093/ndt/gfh348

[13]   M. S. Parmar, “Kidney Stones,” BMJ, Vol. 328, No. 7453, 2004, pp. 1420-1424.
http://dx.doi.org/10.1136/bmj.328.7453.1420

[14]   M. Daudon, O. Traxer, P. Conort, B. Lacour and P. Jungers, “Type 2 Diabetes Increases the Risk for Uric Acid Stones,” Journal of the American Society of Nephrology, Vol. 17, No. 7, 2006, pp. 2026-2033.
http://dx.doi.org/10.1681/ASN.2006030262

[15]   A. Trinchieri, F. Coppi, E. Montanari, A. Del Nero, G. Zanetti and E. Pisani, “Increase in the Prevalence of Symptomatic Upper Urinary Tract Stones during the Last Ten Years,” European Urology, Vol. 37, 2000, pp. 23-25.
http://dx.doi.org/10.1159/000020094

[16]   K. K. Stamatelou, M. E. Francis, C. A. Jones, L. M. Nyberg and G. C. Curhan, “Time Trends in Reported Prevalence of Kidney Stones in the United States: 1976-1994,” Kidney International, Vol. 63, 2003, pp. 1817-1823.
http://dx.doi.org/10.1046/j.1523-1755.2003.00917.x

[17]   K. M. Flegal, M. D. Carroll, C. L. Ogden and C. L. Johnson, “Prevalence and Trends in Obesity among US Adults, 1999-2000,” JAMA, Vol. 288, No. 14, 2002, pp. 1723-1727. http://dx.doi.org/10.1001/jama.288.14.1723

[18]   S. Wild, G. Roglic, A. Green, R. Sicree and H. King, “Global Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030,” Diabetes Care, Vol. 27, No. 5, 2004, pp. 1047-1053.
http://dx.doi.org/10.2337/diacare.27.5.1047

[19]   S. J. Nielsen and B. M. Popkin, “Patterns and Trends in Food Portion Sizes, 1977-1998,” JAMA, Vol. 289, No. 4, 2003, pp. 450-453.
http://dx.doi.org/10.1001/jama.289.4.450

[20]   L. Cordain, S. B. Eaton, A. Sebastian, N. Mann, S. Lindeberg, B. A. Watkins, J. H. O’Keefe and J. Brand-Miller, “Origins and Evolution of the Western Diet: Health Implications for the 21st Century,” American Journal of Clinical Nutrition, Vol. 81, No. 2, 2005, pp. 341-354.

 
 
Top